GlassScriptPhysician profile
George T Maughan
NPI 1558323824
$2,568.63
in general payments reported to CMS, 2019-2025
35 companies · $20.19 in 2025
The $20.19 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $505 · 2020: $526 · 2021: $554 · 2022: $217 · 2023: $92.41 · 2024: $653 · 2025: $20.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $749 · Entertainment: $16.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $748.82 |
| Entertainment | $16.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $262.04 | 2019-2024 | Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $251.29 | 2019-2024 | Tradjenta, Jardiance |
| Glaxosmithkline, LLC. | $213.71 | 2019-2021 | |
| Novo Nordisk INC | $181.10 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $147.65 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $139.12 | 2019-2021 | |
| Pfizer INC. | $131.15 | 2019-2024 | |
| Amgen INC. | $128.85 | 2019-2024 | Repatha, Otezla |
| Astrazeneca Pharmaceuticals LP | $119.94 | 2019-2024 | Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $92.96 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $85.28 | 2019-2024 | |
| Astellas Pharma US INC | $85.17 | 2019-2024 | Veozah |
| Esperion Therapeutics, INC. | $80.54 | 2020-2021 | |
| Abbott Laboratories | $77.49 | 2021-2022 | |
| Biogen, INC. | $55.56 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dynavax Technologies Corporation | $52.18 | 2022-2024 | Heplisav-B |
| Inspire Medical Systems, INC. | $45.68 | 2024-2025 | Inspire |
| Amarin Pharma, INC. | $44.03 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $39.93 | 2019-2021 | |
| Mylan Specialty L.P. | $34.84 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.42 | 2020-2024 | Trintellix |
| Philips North America LLC | $33.36 | 2024 | (Ck6) Holter |
| Merck Sharp & Dohme LLC | $31.03 | 2020-2024 | Gardasil 9, Capvaxive, Gardasil |
| Lundbeck LLC | $25.03 | 2024 | Vyepti |
| Jazz Pharmaceuticals INC. | $21.53 | 2021 | |
| Phathom Pharmaceuticals, INC. | $20.44 | 2024 | Voquezna |
| Daiichi Sankyo INC. | $19.62 | 2024 | Injectafer |
| Sunovion Pharmaceuticals INC. | $18.02 | 2021 | |
| Sanofi Pasteur INC. | $16.74 | 2019 | |
| Optos, INC. | $16.74 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Currax Pharmaceuticals LLC | $14.22 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $13.86 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.24 | 2021 | |
| Allergan, INC. | $12.12 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Maughan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.